A Study to Evaluate Safety and Efficacy of AMZ002 Treatment, Compared With Vigabatrin in Participants With Infantile Spasms

Clinical trial NCT05128344 · WITHDRAWN

Trial details

NCT number: NCT05128344
Sponsor: Amzell
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Spasms, Infantile

Start date: 2023-04-01
Primary completion: 2025-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.